Re: Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer

Phase 1 ◽

High Dose ◽

Phase 1 Trial ◽

Commentary on Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2009.09.009 ◽

2009 ◽

Vol 27 (6) ◽

pp. 692 ◽

Cited By ~ 1

Author(s):

Daniel W. Lin

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

High Dose ◽

Phase 1 Trial ◽

Faculty Opinions recommendation of Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1159522.619900 ◽

2009 ◽

Author(s):

Anders Bjartell

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

High Dose ◽

Phase 1 Trial ◽

Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer

European Urology ◽

10.1016/j.eururo.2009.03.073 ◽

2009 ◽

Vol 56 (2) ◽

pp. 237-244 ◽

Cited By ~ 52

Author(s):

Michael J. Morris ◽

Daisy Huang ◽

William K. Kelly ◽

Susan F. Slovin ◽

Ryan D. Stephenson ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

High Dose ◽

Phase 1 Trial ◽

244 Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC): a Phase 1 Trial in Castration-Resistant Metastatic Prostate Cancer (mCRPC)

European Journal of Cancer ◽

10.1016/s0959-8049(12)72042-7 ◽

2012 ◽

Vol 48 ◽

pp. 75 ◽

Cited By ~ 3

Author(s):

D. Petrylak ◽

P. Kantoff ◽

A. Mega ◽

J. Stephenson ◽

N. Vogelzang ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

Prostate Specific Membrane Antigen ◽

Antibody Drug Conjugate ◽

Phase 1 Trial ◽

Castration Resistant ◽

Antigen Antibody ◽

Specific Membrane ◽

Antibody Drug

High-dose ketoconazole in castration-resistant, metastatic prostate cancer patients previously treated with docetaxel chemotherapy: Single institution retrospective review.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e15151 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e15151-e15151 ◽

Cited By ~ 2

Author(s):

T. Talebi ◽

M. Manoharan ◽

M. S. Soloway ◽

R. Singal

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Retrospective Review ◽

High Dose ◽

Single Institution ◽

Castration Resistant ◽

Previously Treated ◽

Docetaxel Chemotherapy

A Phase 1 Trial of Cabazitaxel Combined With 188Re–Hydroxyethylidene Diphosphonate in Patients With Metastatic Castration-Resistant Prostate Cancer Who Progressed on or After a Docetaxel-Containing Treatment

Clinical Nuclear Medicine ◽

10.1097/rlu.0000000000001604 ◽

2017 ◽

Vol 42 (6) ◽

pp. 415-420 ◽

Cited By ~ 2

Author(s):

Joyce M. van Dodewaard-de Jong ◽

Esther W. Bouman-Wammes ◽

Haiko J. Bloemendal ◽

Henk M.W. Verheul ◽

John M.H. de Klerk ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

Castration Resistant Prostate Cancer ◽

Phase 1 Trial ◽

Reply to Tomasz Drewa and Piotr Chlosta’s Letter to the Editor re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate. Eur Urol 2009;56:237–44

European Urology ◽

10.1016/j.eururo.2009.10.022 ◽

2010 ◽

Vol 57 (2) ◽

pp. e20

Author(s):

Michael J. Morris ◽

Howard I. Scher

Keyword(s):

Phase 1 ◽

High Dose ◽

Phase 1 Trial ◽

Castration Resistant ◽

Letter To The Editor

Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate. Eur Urol 2009;56:237–44

European Urology ◽

10.1016/j.eururo.2009.10.021 ◽

2010 ◽

Vol 57 (2) ◽

pp. e18-e19 ◽

Cited By ~ 1

Author(s):

Tomasz Drewa ◽

Piotr Chlosta

Keyword(s):

Phase 1 ◽

High Dose ◽

Phase 1 Trial ◽

Abiraterone acetate plus prednisone/prednisolone in hormone-sensitive and castration-resistant metastatic prostate cancer

Expert Review of Precision Medicine and Drug Development ◽

10.1080/23808993.2021.1863781 ◽

2020 ◽

pp. 1-9

Author(s):

Jürgen E Gschwend ◽

Kurt Miller

Keyword(s):

Prostate Cancer ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Hormone Sensitive

Efficacy of abiraterone acetate in castration‐resistant metastatic prostate cancer: A real‐world data analysis

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.13426 ◽

2020 ◽

Author(s):

Abdilkerim Oyman ◽

Mustafa Başak ◽

Melike Özçelik ◽

Deniz Tataroğlu Özyükseler ◽

Selver Işık ◽

...

Keyword(s):

Prostate Cancer ◽

Data Analysis ◽

Real World ◽

Abiraterone Acetate ◽

Real World Data ◽

World Data ◽